Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eydo Pharma SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11301
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eydo Pharma SAS (Eydo Pharma) develops anti-bacterial medicines from essential oils and natural plant molecules for the treatment of infections caused by resistant bacteria. The company developed a pipeline of compounds and formulations such as EP1012, EP1010, EP1011, EP1014, EP1015, EP1020 and EP1030 to treat multi-antibiotic resistant infections, pathogenic bacterial strains and hospital acquired infections (HAI, nosocomial diseases). Its proprietary drug delivery technologies for the in vivo delivery of therapeutic lipophilic and active compounds include Aquaphile system, Lipidic Nano Capsules and Nano Beads through routes of administration such as intravenous and oral. The company works in partnership with universities and research centers including Inserm (French National Institute of Health and Medical Research). Eydo pharma is headquartered in Chartres, France.

Eydo Pharma SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eydo Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Eydo Pharma Raises Funds in Financing 10
Eydo Pharma Raises Funds in Second Round Financing 11
Eydo Pharma Raises Funds in First Round Financing 12
Eydo Pharma SAS – Key Competitors 13
Eydo Pharma SAS – Key Employees 14
Eydo Pharma SAS – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Key Facts 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eydo Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eydo Pharma SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eydo Pharma Raises Funds in Financing 10
Eydo Pharma Raises Funds in Second Round Financing 11
Eydo Pharma Raises Funds in First Round Financing 12
Eydo Pharma SAS, Key Competitors 13
Eydo Pharma SAS, Key Employees 14
Eydo Pharma SAS, Other Locations 15

List of Figures
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • API Technologies Corp.:戦略・SWOT・企業財務分析
    API Technologies Corp. - Strategy, SWOT and Corporate Finance Report Summary API Technologies Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Blue Apron Holdings Inc (APRN):企業の財務・戦略的SWOT分析
    Blue Apron Holdings Inc (APRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Fiesta Mart LLC:企業の戦略的SWOT分析
    Fiesta Mart LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Elementis plc (ELM):企業の財務・戦略的SWOT分析
    Elementis plc (ELM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Lentigen Technology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lentigen Technology Inc (Lentigen), a subsidiary of Miltenyi Biotec GmbH, is a provider of gene delivery and expression technology solutions. The company provides clinical trial support in viral vector product development and clinical applications, among others. Its lentiviral vectors finds …
  • Sanmina Corporation (SANM):企業の財務・戦略的SWOT分析
    Sanmina Corporation (SANM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Primary Health Care Ltd (PRY):企業の財務・戦略的SWOT分析
    Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Comet Ridge Ltd (COI):企業の財務・戦略的SWOT分析
    Summary Comet Ridge Ltd (CRL) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company holds interests in Mahalo project located in the Denison trough area of Queensland's Bowen Basin near Rolleston. It also holds interest in PEL 6 …
  • Group 1 Automotive, Inc.:企業のM&A・事業提携・投資動向
    Group 1 Automotive, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Group 1 Automotive, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Prominence Energy NL (SUR):企業の財務・戦略的SWOT分析
    Summary Prominence Energy NL(Prominence Energy) formerly known as Sun Resources NL is an oil and gas exploration and development company. The company explores and develops crude oil and natural gas. Its services include exploration, production, and development of unconventional oil and gas resources …
  • Garvan Institute of Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Garvan Institute of Medical Research (Garvan Institute) is a biomedical institute that offers research services. The institute conducts research in the fields of cancer, diabetes and obesity, Alzheimer’s and Parkinson’s disease, asthma, rheumatoid arthritis, osteoporosis, arthritis and pitui …
  • Fiskars Corporation:企業の戦略・SWOT・財務情報
    Fiskars Corporation - Strategy, SWOT and Corporate Finance Report Summary Fiskars Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • PT. Indonesia Power:発電所・企業SWOT分析
    PT. Indonesia Power - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Flexion Therapeutics Inc (FLXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Flexion Therapeutics Inc (Flexion) develops and commercializes pain therapies. The company's pipeline is focused on indications that includes osteoarthritis knee pain (repeat administration), osteoarthritis knee synovial inflammation, bilateral knee osteoarthritis pain shoulder and hip osteo …
  • China UnionPay Company Ltd:企業の戦略・SWOT・財務情報
    China UnionPay Company Ltd - Strategy, SWOT and Corporate Finance Report Summary China UnionPay Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • NeoGenomics Inc (NEO):医療機器:M&Aディール及び事業提携情報
    Summary NeoGenomics Inc (NeoGenomics) is a cancer diagnostics and pharma services company that offers diagnostic, prognostic and predictive testing services. The company offers testing services with various technologies such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immuno …
  • Coloplast AS (COLO B):医療機器:M&Aディール及び事業提携情報
    Summary Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advance …
  • PT XL Axiata Tbk (EXCL):企業の財務・戦略的SWOT分析
    PT XL Axiata Tbk (EXCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Upsher-Smith Laboratories Inc:企業のM&A・事業提携・投資動向
    Upsher-Smith Laboratories Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Upsher-Smith Laboratories Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆